1992
DOI: 10.1111/j.1365-2141.1992.tb08224.x
|View full text |Cite
|
Sign up to set email alerts
|

Trace Levels of Factor Viii in Substrate Plasma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2000
2000
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 3 publications
0
5
0
Order By: Relevance
“…Although attempts were made to minimize variability by using single lots of reagents, standards, and substrate plasmas, interassay CVs for factors VII and IX were >10%. Different substrate plasmas contained different residual levels of clotting factor activity, and these trace levels affect the linearity of standard curves 14 , 15 . In this study, the relatively high FVII:C and low FIX:C in the test plasmas may have been caused in part by variation in residual activities of the substrate plasmas.…”
Section: Discussionmentioning
confidence: 68%
See 1 more Smart Citation
“…Although attempts were made to minimize variability by using single lots of reagents, standards, and substrate plasmas, interassay CVs for factors VII and IX were >10%. Different substrate plasmas contained different residual levels of clotting factor activity, and these trace levels affect the linearity of standard curves 14 , 15 . In this study, the relatively high FVII:C and low FIX:C in the test plasmas may have been caused in part by variation in residual activities of the substrate plasmas.…”
Section: Discussionmentioning
confidence: 68%
“…Different substrate plasmas contained different residual levels of clotting factor activity, and these trace levels affect the linearity of standard curves. 14,15 In this study, the relatively high FVII:C and low FIX:C in the test plasmas may have been caused in part by variation in residual activities of the substrate plasmas. A single set of dilutions of the CP2D reference plasma was used to derive standard curves for all factors on each assay date.…”
Section: Wardrop Brooksmentioning
confidence: 86%
“…In an attempt to account for this variability, each factor activity was measured twice for every unit and repeated if >10% discrepancy was observed, and a single lot of reagents was used, as different reagents and substrate plasmas could contain different residual levels of coagulation factor activity, affecting the linearity of standard curves. 32 Another limitation was that when calculating the recommended dose, information on the number of IUs required for clinical effectiveness was extrapolated from canine publications and calculated along with in vitro results of the present study. Further feline in vivo studies should be performed to confirm our dose recommendation.…”
Section: Discussionmentioning
confidence: 99%
“…In an attempt to account for this variability, each factor activity was measured twice for every unit and repeated if >10% discrepancy was observed, and a single lot of reagents was used, as different reagents and substrate plasmas could contain different residual levels of coagulation factor activity, affecting the linearity of standard curves. 32…”
Section: Discussionmentioning
confidence: 99%
“…An example of this is provided by the observations on the apparent influence of vWF on observed factor VIII activity (51,52). The presence of trace amounts of factor VIII in the substrate plasma also can influence results (78). Finally, there is evidence that each factor VIII-deficient plasma will give a somewhat unique slope for the standard curve.…”
Section: In Vitro Assay Systems For Factor VIIImentioning
confidence: 99%